Past studies

Home / Past studies


SponsorStudy Target population Status
MedicagoFlu vaccine for elderly: dose comparison2 groups:
18-49 years of age
≥ 65 years of age
MedicagoFlu vaccine for adultsHealthy adultsCompleted
VBIHepatitis B vaccineAdults in stable healthCompleted
Investigator initiatedFlu vaccineAdults with Rheumatoid arthritisCompleted


SponsorStudy Target population Status
Merck Pneumococcal vaccine NewbornsCompleted
MedImmuneMonoclonal antibody against Respiratory Syncytial Virus (RSV)Healthy preterm infantsCompleted

These are only the recent, completed, vaccine studies.  We have successfully conducted over 100 studies”